Skip to main content

Share story

Infrastructure

Inspire Semiconductor holds shareholder business update webinar

Inspire Semiconductor Holdings Inc. announced that it will hold a business update for shareholders by live webinar at 11 a.m. US Central Time on Wednesday, March 4, 2026. The webinar link will be posted to the investors page of the InspireSemi website at least one week prior to the call. The company is headquartered in Austin, Texas. Inspire Semiconductor Holdings Inc. is a chip design company that provides high performance, energy efficient accelerated computing solutions for high performance computing, artificial intelligence, graph analytics and other compute intensive workloads. The Thunderbird I supercomputer cluster on a chip is a datacenter accelerator designed to address multiple underserved and diversified industries, including financial services, computer aided engineering, energy, climate modeling, cybersecurity and life sciences and drug discovery. The solutions are based on the open standard RISC-V instruction set architecture. The company said its solutions set new standards of performance, energy efficiency and ease of programming. The webinar is intended to provide shareholders with a business update.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from InspireSemi and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.